Nixxi Developing Mass Spec Test Targeting Preterm Birth Space

We are pleased to share 360dx’s profile of Nixxi. Our company is focused on creating clinical tools that address the most critical segment of premature births – those delivered prior to 32 weeks. Additionally, as reported, we are exploring solutions from another perspective – the ability to accurately predict neonatal outcomes early in pregnancy.